Meta Platforms (META) News Today

Meta Platforms, Inc. (NASDAQ: META) shares have been under pressure, and the latest move appears tied to a mix of investor concern over heavy AI spending and a few headline risks, even as Wall Street remains constructive on the long-term story.

• Positive Sentiment: UBS kept a buy rating on Meta while lowering its price target to $766 from $865, implying meaningful upside from current levels and signaling analysts still see room for gains despite recent volatility.
• Positive Sentiment: Multiple articles highlighted Meta’s expanded AI ambitions, including a major scale-up of its Louisiana Hyperion data center to 5 gigawatts and more than $50 billion in projected cost, reinforcing the company’s commitment to AI infrastructure and long-term growth.
• Positive Sentiment: Some market commentary framed Meta as one of the strongest mega-cap AI stories, citing its ability to fund AI investment with a profitable ad business and noting that its new AI model is priced well below rivals, which could help adoption.
• Neutral Sentiment: Several reports focused on technical factors, saying META looked overbought and near resistance, which may be contributing to short-term weakness rather than reflecting a change in fundamentals.
• Negative Sentiment: Investors are also weighing concerns that Meta’s AI spending is rising fast, with 2026 capex now expected at $125 billion to $145 billion, raising questions about near-term returns on investment and pressuring sentiment.
• Negative Sentiment: Meta pulled down an AI image tool after privacy backlash, and the company is facing criticism over AI advertising tools that allegedly create poor results for brands, adding reputational and regulatory noise.
• Negative Sentiment: Additional headlines noted a Chinese regulatory setback on a planned AI acquisition and an EU probe into Facebook and Instagram design features, which could increase legal and compliance uncertainty.

Overall, META is being driven by the tension between its powerful AI growth narrative and rising concerns about spending, execution, and regulation. The stock’s recent decline looks more like a reaction to those risks and technical overbought signals than to weakening core business momentum.